Quantbot Technologies LP Oric Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$8.04 - $16.03 $45,827 - $91,371	5,700 New	5,700 $78,000
Q1 2023 May 12, 2023	BUY	$4.26 - $6.75 $10,564 - $16,740	2,480 New	2,480 $14,000
Q2 2022 Aug 09, 2022	SELL	$2.7 - $7.07 $39,150 - $102,515	-14,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.54 - $16.1 $65,830 - $233,450	14,500 New	14,500 $77,000
Q4 2021 Feb 11, 2022	SELL	$12.01 - $20.3 $32,427 - $54,810	-2,700 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$15.9 - $25.22 $42,930 - $68,094	2,700 New	2,700 $56,000

112

63.1M

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $406M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.